Premium
FS04.8
The U.S. Cosmetic Ingredient Review: process and products
Author(s) -
McEwen Gerald
Publication year - 2004
Publication title -
contact dermatitis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.524
H-Index - 96
eISSN - 1600-0536
pISSN - 0105-1873
DOI - 10.1111/j.0105-1873.2004.0309aq.x
Subject(s) - cosmetics , active ingredient , ingredient , medicine , food and drug administration , population , cosmetic industry , business , dermatology , environmental health , pharmacology , pathology
The U.S. Cosmetic Ingredient Review (CIR) program has evaluated safety in use data on approximately 1300 ingredient since 1976. The review process, which relies on open public meetings and the active participation of the public, the U.S. Food and Drug Administration, and the cosmetics and chemical industries, has identified many cosmetic ingredients that should only be used under limited conditions. Adhearance to the limitations on use in the conclusions of the CIR reports, in the U.S., appears to have limited exposure and patient population sensitivity to some widely used cosmetic ingredients that have produced high rates of reactions in Europe. The advantages of the CIR process for the public and the medical community; the deliberations leading to the use limitations on two example ingredients, and sources for attendees to locate CIR Reports and conclusions will be presented.